Valuing the effect sizes hypothesized in phase 3 trials of targeted therapies in oncology

This abstract was not included in this publication as it was already published. See Annals of Oncology, Volume 27, Issue suppl_6, 1 October 2016, 317P (10.1093/annonc/mdw366.02) - Oxford University Press.

Detalhes bibliográficos
Principais autores: Reilly, G, Wise, A, Attwood, S, Scudder, C, Love, S
Formato: Conference item
Publicado em: BioMed Central 2017